Topic

Mike Hollan is an assistant managing editor for 

 and can be reached at mhollan@mjhlifesciences.com.

Articles

Industry experts discuss the relationship between digital and traditional (key) opinion leaders and how companies are adjusting their strategies to harness the unique brand engagement benefits each role can provide in driving better patient outcomes.

An Evolving ‘Opinion’ Landscape: New Paths—and Synergies—for Pharma KOLs & DOLs

Five industry experts discuss labeling challenges and trends in modernization.

Executive Roundtable: Innovations in Global Pharma Labeling

Francis Pollaro is a former senior editor for 

Join five industry leaders as they unpack the transformative potential of artificial intelligence in   the pharmaceutical industry, offering insights into real-world applications and the future of life sciences marketing in an era shaped by rapid technological evolution.

The AI Revolution Has Arrived: Shaping the Next Generation of Pharma Marketing 

Marketing leaders discuss the powerful role life sciences companies can play in the expanding digital landscape for healthcare communications—as “one of the helpful voices” in driving the customer and patient conversations that matter most.

The Ascendancy of Social Media: Fitting Pharma Brand Teams Into the Conversation Mix

Chief financial officers and other finance experts discuss the continued market volatility impacting life sciences investment—and what biopharma companies can do to help accelerate its recovery. Quality science and “good data” still win the day.

Focus and Fundamentals: CFO Strategies on the Journey to Commercialization

Senior leaders focused on the advancement of digital medicine and health meet to discuss the importance of these tools for life sciences companies, payers, and others in harnessing a healthcare future that will be increasingly dominated by holistic treatment and delivery.

Whole-Person Care: Are We Ready? The Intersection of Pharma and Digital Therapeutics

Senior leaders in pharma, healthcare marketing and communications, and advertising got together to discuss the progress and lingering roadblocks in advancing diversity, equity, and inclusion strategies in the life sciences—where the common thread seems clear: the messenger matters.

DE&I in Pharma Sales & Marketing: ‘While There’s Work, There’s Promise’

Julian Upton is a contributing editor for 

Biopharma experts at the forefront of applying real-world data and real-world evidence across the product life cycle converge to discuss the lingering challenges in fully realizing the vast potential of these insights to transform the value equation.

Data Vigilance and Validation: Lessons Learned, Future Hopes for Real-World Data

Lisa Henderson is the former group editorial director of 

Our latest CEO Leadership roundtable focused on the most top-of-mind issues for companies.

Ready for Pharma’s Next Chapter

Chief commercial officers gather for an insightful roundtable discussion anchored in the future of sales and marketing in light of new communication media brought on by the pandemic.